These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2970276)

  • 1. Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis.
    Vezzani A; Wu HQ; Angelico P; Stasi MA; Samanin R
    Brain Res; 1988 Jun; 454(1-2):289-97. PubMed ID: 2970276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection: evidence for a dissociation between neurochemical changes and seizures.
    Vezzani A; Ungerstedt U; French ED; Schwarcz R
    J Neurochem; 1985 Aug; 45(2):335-44. PubMed ID: 3159848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the potential neurotoxic and convulsant effects of increased blood levels of quinolinic acid in rats with altered blood-brain barrier permeability.
    Vezzani A; Stasi MA; Wu HQ; Castiglioni M; Weckermann B; Samanin R
    Exp Neurol; 1989 Oct; 106(1):90-8. PubMed ID: 2551719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of l-daurisoline on quinolinic acid-induced Ca2+ influx in hippocampus neurons in freely moving rats.
    Lu YM; Liu GQ
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):301-4. PubMed ID: 1807076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizure activity and lesions after intrahippocampal quinolinic acid injection.
    Schwarcz R; Brush GS; Foster AC; French ED
    Exp Neurol; 1984 Apr; 84(1):1-17. PubMed ID: 6705878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The neurodegenerative and convulsant action of quinolinic acid].
    Kozlovskiĭ VL; Prakh'e IV; Geĭnisman NV
    Neirofiziologiia; 1990; 22(3):354-9. PubMed ID: 2144614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ca2+ antagonists on glutamate release and Ca2+ influx in the hippocampus with in vivo intracerebral microdialysis.
    Lu YM; Zhang JT; Zhao FQ; Qin YF
    Br J Pharmacol; 1991 Sep; 104(1):222-6. PubMed ID: 1686204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrahippocampal quinolinic acid infusion on the amygdala kindling in rat.
    Ping HX; Liu GQ; Xie L; Wu HQ
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):304-7. PubMed ID: 1807077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
    Vezzani A; Wu HQ; Tullii M; Samanin R
    J Pharmacol Exp Ther; 1986 Oct; 239(1):256-63. PubMed ID: 2945004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A noradrenergic component of quinolinic acid-induced seizures.
    Vezzani A; Schwarcz R
    Exp Neurol; 1985 Oct; 90(1):254-8. PubMed ID: 2931301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peptidase-resistant cyclic octapeptide analogue of somatostatin (SMS 201-995) modulates seizures induced by quinolinic and kainic acids differently in the rat hippocampus.
    Vezzani A; Serafini R; Stasi MA; Viganò G; Rizzi M; Samanin R
    Neuropharmacology; 1991 Apr; 30(4):345-52. PubMed ID: 1830135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine modulates seizures induced by quinolinic acid in rats: selective and distinct roles of alpha-adrenoceptor subtypes.
    Wu HQ; Tullii M; Samanin R; Vezzani A
    Eur J Pharmacol; 1987 Jun; 138(3):309-18. PubMed ID: 3040437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds.
    Foster AC; Collins JF; Schwarcz R
    Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro.
    French ED; Vezzani A; Whetsell WO; Schwarcz R
    Adv Exp Med Biol; 1986; 203():349-62. PubMed ID: 2947421
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of kynurenic acid synthesis studied by microdialysis in the dorsal hippocampus of unanesthetized rats.
    Wu HQ; Ungerstedt U; Schwarcz R
    Eur J Pharmacol; 1992 Mar; 213(3):375-80. PubMed ID: 1535598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the interaction of 2-amino-7-phosphono-heptanoic acid and quinolinic acid in mice.
    Perkins MN; Stone TW
    Eur J Pharmacol; 1983 May; 89(3-4):297-300. PubMed ID: 6347698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative potencies of (-)-2-amino-5-phosphonovalerate and (-)-2-amino-7-phosphonoheptanoate as antagonists of N-methylaspartate and quinolinic acids and repetitive spikes in rat hippocampal slices.
    Stone TW
    Brain Res; 1986 Aug; 381(1):195-8. PubMed ID: 2875764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
    Ganong AH; Cotman CW
    J Pharmacol Exp Ther; 1986 Jan; 236(1):293-9. PubMed ID: 2867215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo release of [3H]-purines by quinolinic acid and related compounds.
    Perkins MN; Stone TW
    Br J Pharmacol; 1983 Oct; 80(2):263-7. PubMed ID: 6317129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electroencephalographic manifestations of the convulsive reaction of rats to the intraventricular administration of quinolinic acid and kynurenine].
    Kozlovskiĭ VB; Prakh'e IV
    Farmakol Toksikol; 1988; 51(6):26-9. PubMed ID: 2976682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.